´ëÇÑÀ忬±¸ÇÐȸ ´ë±¸°æºÏÁöȸ 2024³â Á¦7ȸ ¿¬¼ö°Á : 2024-01-20
±³À°ÀÏÀÚ : 2024-01-20
±³À°Àå¼Ò : ´ë±¸°¡Å縯´ëÇб³ ÀÇ°ú´ëÇÐ µ¥·¹»ç°ü
±³À°ÁÖÁ¦ : ´ëÇÑÀ忬±¸ÇÐȸ ´ë±¸°æºÏÁöȸ 2024³â Á¦7ȸ ¿¬¼ö°ÁÂ
ÁÖÃÖ±â°ü : ´ëÇÑÀ忬±¸ÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ë±¸ °æºÏ Áöȸ
´ã´çÀÚ : ±èÇýÀÎ
¿¬¶ôó : 02-957-6145
À̸ÞÀÏ : ccaid@naver.com
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª : ´ë±¸±¤¿ª½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 14:00~14:20 Drug induced enterocolitis A to Z Ȳ¼º¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 14:20~14:40 Functional GI disorders in children ÃÖº´È£(°æºÏÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 14:40~15:00 Constipation ÀÌÀ¯Áø(°è¸íÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 15:00~15:20 Acute diverticulitis ±è¹Îö(¿µ³²ÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 15:20~15:40 Post polypectomy surveillance Á¶ÇüÈ£(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 16:00~16:20 Anti-TNF and anti-integrin ÀÌÇö¼®(°æºÏÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 16:20~16:40 JAK inhibitors and S1P modulators À± Çõ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 16:40~17:00 Anti-interleukins ¹® ¿ø(°í½ÅÀÇ´ë)
±³À°½Ã°£ 01¿ù 20ÀÏ µ¥·¹»ç°ü 17:00~17:20 Sharing tips for positioning IBD therapies õÀçÈñ(¿¬¼¼ÀÇ´ë)
Åä·Ð 01¿ù 20ÀÏ µ¥·¹»ç°ü 17:20~17:50 Case based discussion ·ùÇÑÁØ(´ë±¸ÆÄƼ¸¶º´¿ø)